Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6933)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pai SG, Fuloria J. Novel therapeutic agents in the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2016; 8(1): 99-104 [PMID: 26798440 DOI: 10.4251/wjgo.v8.i1.99] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i1/99.htm |
| Number | Citing Articles |
| 1 |
Reiko Satow, Yudai Suzuki, Shinobu Asada, Sae Ota, Masashi Idogawa, Shiori Kubota, Noi Ikeo, Atsuko Yoneda, Kiyoko Fukami. Downregulation of protein kinase C gamma reduces epithelial property and enhances malignant phenotypes in colorectal cancer cells. iScience 2022; 25(12): 105501 doi: 10.1016/j.isci.2022.105501
|
| 2 |
Allison A. Aka, Jeff A. Rappaport, Amanda M. Pattison, Takami Sato, Adam E. Snook, Scott A. Waldman. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer. Expert Review of Clinical Pharmacology 2017; 10(5): 549 doi: 10.1080/17512433.2017.1292124
|
| 3 |
Jeffrey Q. Nguyen, Rosalyn B. Irby. TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells. Cancer Biology & Therapy 2017; 18(1): 16 doi: 10.1080/15384047.2016.1252880
|
| 4 |
Chun Loong Ho, Hui Qing Tan, Koon Jiew Chua, Aram Kang, Kiat Hon Lim, Khoon Lin Ling, Wen Shan Yew, Yung Seng Lee, Jean Paul Thiery, Matthew Wook Chang. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nature Biomedical Engineering 2018; 2(1): 27 doi: 10.1038/s41551-017-0181-y
|
| 5 |
Shakir Idris, Bassem Refaat, Riyad A. Almaimani, Hussain G. Ahmed, Jawwad Ahmad, Mai Alhadrami, Mahmoud Zaki El-Readi, Mohamed E. Elzubier, Haneen A.A. Alaufi, Badriah Al-Amin, Ahmad A. Alghamdi, Fayez Bahwerth, Faisal Minshawi, Saeed M. Kabrah, Akhmed Aslam. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway. Life Sciences 2022; 296: 120442 doi: 10.1016/j.lfs.2022.120442
|
| 6 |
Ankit Srivastava, Sandhya Rai, Deepa Bisht, Manisha Sachan, Bimal Prasad Jit, Sameer Srivastava. Protein Kinase Inhibitors. 2022; : 361 doi: 10.1016/B978-0-323-91287-7.00007-7
|
| 7 |
Hossein M Abdolahi, Ali S Asiabar, Saber Azami-Aghdash, Fatemeh Pournaghi-Azar, Aziz Rezapour. Cost-effectiveness of colorectal cancer screening and treatment methods: Mapping of systematic reviews. Asia-Pacific Journal of Oncology Nursing 2018; 5(1): 57 doi: 10.4103/apjon.apjon_50_17
|
| 8 |
Bassem Refaat, Adel Galal El-Shemi, Amr Mohamed Mohamed, Osama Adnan Kensara, Jawwad Ahmad, Shakir Idris. Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2914-9
|
| 9 |
Akhmed Aslam, Jawwad Ahmad, Mohammed A. Baghdadi, Shakir Idris, Riyad Almaimani, Aiman Alsaegh, Mai Alhadrami, Bassem Refaat. Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021; 1867(3): 166040 doi: 10.1016/j.bbadis.2020.166040
|
| 10 |
Osman Ali, Mazen Tolaymat, Shien Hu, Guofeng Xie, Jean-Pierre Raufman. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(2): 716 doi: 10.3390/ijms22020716
|
| 11 |
Amanda M Pattison, Dante J Merlino, Erik S Blomain, Scott A Waldman. Guanylyl cyclase C signaling axis and colon cancer prevention. World Journal of Gastroenterology 2016; 22(36): 8070-8077 doi: 10.3748/wjg.v22.i36.8070
|
| 12 |
Qian Yao, Yu An, Wei Hou, Ya-Nan Cao, Meng-Fei Yao, Ning-Ning Ma, Lin Hou, Hong Zhang, Hai-Jing Liu, Bo Zhang. LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics. Oncotarget 2017; 8(65): 109632 doi: 10.18632/oncotarget.22759
|
| 13 |
Junjun Chen, Jie Dai, Zhiming Kang, Ting Yang, Qi Zhao, Jinxiu Zheng, Xinxin Zhang, Jisheng Zhang, Jun Xu, Gongqin Sun, Lijun Yang, Tao Yang. A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer. Experimental Cell Research 2020; 393(1): 112060 doi: 10.1016/j.yexcr.2020.112060
|
| 14 |
Andreas Seeber, Günther Gastl. Targeted Therapy of Colorectal Cancer. Oncology Research and Treatment 2016; 39(12): 796 doi: 10.1159/000453027
|
| 15 |
Jung Wook Yang, Yoon-La Choi. Genomic profiling of esophageal squamous cell carcinoma (ESCC)—Basis for precision medicine. Pathology - Research and Practice 2017; 213(7): 836 doi: 10.1016/j.prp.2017.02.021
|
| 16 |
I. Kiss, J. Mlčochová, K. Součková, P. Fabian, A. Poprach, J. Halamkova, M. Svoboda, R. Vyzula, O. Slaby. MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX. Oncology Letters 2017; 14(1): 743 doi: 10.3892/ol.2017.6255
|
| 17 |
José Carlos Méndez Méndez, Mercedes Salgado Fernández, Juan de la Cámara Gómez, Mari Luz Pellón Augusto, Marta Covela Rua, Guillermo Quintero Aldana, Ana Fernández Montes, Margarida Reboredo López, Manuel Valladares Ayerbes, Mónica Jorge Fernández, Paula González Villarroel, Carlos Romero Reinoso, Manuel Ramos Vázquez. First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study. Journal of Geriatric Oncology 2020; 11(8): 1263 doi: 10.1016/j.jgo.2020.06.003
|
| 18 |
Omar Al-Obeed, Adila Salih El-Obeid, Sabine Matou-Nasri, Mansoor-Ali Vaali-Mohammed, Yazeid AlHaidan, Mohammed Elwatidy, Hamad Al Dosary, Zeyad Alehaideb, Khayal Alkhayal, Adil Haseeb, James McKerrow, Rehan Ahmad, Maha-Hamadien Abdulla. Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01206-x
|